Chien Hsi Chen

Senior Scientist @ AnnJi Pharmaceutical Co., Ltd.

Country

Taiwan

City

Taipei

Industry

Biotechnology

Skill

iPSC characterization, iPSC culture, Pharmacokinetics, stroke animal model, IACUC, Neuropathic pain animal model, Pharmacodynamics, Immunohistochemistry staining, Mammalian Cell Culture, Embryonic stem cell culture, Flowcytometry, Primary Cell Isolation, Disease animal model, 分子選殖

Experience

Senior Scientist

AnnJi Pharmaceutical Co., Ltd.

2024-11 - Present · 1 yr 11 mos

Senior Research Investigator

BeiGene

2022-1 - 2024-10 · 2 yrs 10 mos

Scientist

Lumosa Therapeutics Co., Ltd.

2020-6 - 2021-12 · 1 yr 7 mos

台灣台北

Assosiated Scientist

Lumosa Therapeutics Co., Ltd.

2017-1 - 2020-6 · 3 yrs 6 mos

Taipei

Postdoctoral Fellow

Academia Sinica

2014-2 - 2016-12 · 2 yrs 11 mos

Academia Sinica Postdoctoral Fellows Program at Academia Sinica with Dr. Patrick Hsieh • Examined the therapeutic effect of human placenta derived cell in chronic heart failure. • Identified ideal therapeutic time window for autologous bone marrow cell combined nanofiber therapy in acute myocardial infarction. • Examined the therapeutic effect of human cord blood cell combined hyaluronan hydrogel in myocardial infarction pig. • Differentiated human embryonic stem cell and human induced pluripotent stem cell into hepatocyte like cell. • Identified the function of WT1 protein in cardiomyocyte; hyaluronan hydrogel combined bone marrow stem cell therapy in acute myocardial infarction

Research assistant

Academia Sinica

2008-9 - 2009-9 · 1 yr 1 mo

Examined the function of pluripotent genes such as Sox2, c-myc, Oct4, and Klf4 in mouse cardiomyocyte. • Mouse embryonic stem cell culture/ESC derived cardiomyocye differentiation